Culture of Malignant Pleural Mesothelioma Cells and the Effects of CDKN2B on Cancer Cell

Xiaochuan YIN; Ruiyang YIN; Ranhua LI; Fangqi CAI; Yue CUI; Tao BI; Xinghe TONG

doi:10.12259/j.issn.2095-610X.S20240105

Volume 45 Issue 1

Jan. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(1): 28-34

Xiaochuan YIN, Ruiyang YIN, Ranhua LI, Fangqi CAI, Yue CUI, Tao BI, Xinghe TONG. Culture of Malignant Pleural Mesothelioma Cells and the Effects of CDKN2B on Cancer Cell[J]. Journal of Kunming Medical University, 2024, 45(1): 28-34. doi: 10.12259/j.issn.2095-610X.S20240105

Citation:

Xiaochuan YIN, Ruiyang YIN, Ranhua LI, Fangqi CAI, Yue CUI, Tao BI, Xinghe TONG. Culture of Malignant Pleural Mesothelioma Cells and the Effects of CDKN2B on Cancer Cell[J]. Journal of Kunming Medical University, 2024, 45(1): 28-34. doi: 10.12259/j.issn.2095-610X.S20240105

Citation:

PDF( 3031 KB)

Culture of Malignant Pleural Mesothelioma Cells and the Effects of CDKN2B on Cancer Cell

doi: 10.12259/j.issn.2095-610X.S20240105

1.
Dept. of Thoracic Surgery，The 1st Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032
2.
The 2nd Clinical Medicine Department，Kunming Medical University HaiYuan College，Kunming Yunnan 651700，China

Received Date: 2023-10-09
Available Online: 2023-12-19
Publish Date: 2024-01-25

Abstract

Abstract

Objective To investigate the effects of different culture conditions（RPMI-1640, DMEM and DMEM/F12 medium） on the passage of MPM cells isolated from the tissues of Malignant pleural mesothelioma（MPM）, and to study the effects of CDKN2B on the proliferation, invasion and apoptosis of MPM cells. Methods MPM cells were isolated from MPM tissues and cultured in RPMI-1640, DMEM and DMEM/F12 medium, respectively. Cell proliferation was examined by CCK-8, and the nuclei and chromosomes were observed by Wright-Giemsa staining. Fluorescence intensities of Calretinin, CD141, CK5, EMA and WT-1 were conducted by immunofluorescence assay. The mRNA and protein expression of CDKN2B were detected by RT-qPCR and Western blot, respectively. Transwell was used to detect cell invasion and flow cytometry was used to detect cell apoptosis. Results The established MPM cells showed good viability when passaged to the 10th generation in RPMI-1640, DMEM and DMEM/F12 cultures, and the MPM markers Calretinin, CD141, CK5, EMA and WT-1 were all expressed in the cells. The viability of MPM cells in RPMI-1640 culture medium was relatively stable. CDKN2B was downregulated in MPM cells（P < 0.05）, and overexpression of CDKN2B significantly suppressed the proliferation（P < 0.05）, invasion（P < 0.05） and epithelial interstitial transformation of MPM cells（P < 0.01）, and promoted the apoptosis（P < 0.01）. Conclusion The established MPM cells were stably passaged in RPMI-1640 culture medium, and CDKN2B may be a potential target for the diagnosis and treatment of MPM.
- Malignant pleural mesothelioma,
- Culture conditions,
- RPMI-1640 culture medium,
- CDKN2B,
- Proliferation,
- Invasion

FullText(HTML)

References(22)

References

[1]	Bruno R,Alì G,Fontanini G. Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: A literature review[J]. J Thorac Dis,2018,10(Suppl 2):S342-S352.
[2]	Stumphius J,Meyer P B. Asbestos bodies and mesothelioma[J]. Ann Occup Hyg,1968,11(4):283-293.
[3]	Porret E, Madelaine J, Galateau-Sallé F, et al. Epidemiology, molecular biology, diagnostic and therapeutic strategy of malignant pleural mesothelioma in 2007 - an update[J]. Rev Mal Respir, 2007, 24（8 Pt 2）: 6S157-6S164.
[4]	Robinson B W,Musk A W,Lake R A. Malignant mesothelioma[J]. Lancet,2005,366(9483):397-408. doi: 10.1016/S0140-6736(05)67025-0
[5]	Santoro A,O'brien M E,Stahel R A,et al. Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: Results of the international expanded access program[J]. J Thorac Oncol,2008,3(7):756-763. doi: 10.1097/JTO.0b013e31817c73d6
[6]	Macleod N,Chalmers A,O'rourke N,et al. Is radiotherapy useful for treating pain in mesothelioma? A phase ii trial[J]. J Thorac Oncol,2015,10(6):944-950. doi: 10.1097/JTO.0000000000000499
[7]	Clive A O,Taylor H,Dobson L,et al. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): A multicentre,open-label,phase 3,randomised controlled trial[J]. Lancet Oncol,2016,17(8):1094-1104. doi: 10.1016/S1470-2045(16)30095-X
[8]	Zalcman G,Mazieres J,Margery J,et al. Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma avastin cisplatin pemetrexed study (MAPS): A randomised,controlled,open-label,phase 3 trial[J]. Lancet,2016,387(10026):1405-1414. doi: 10.1016/S0140-6736(15)01238-6
[9]	Chernova T,Sun X M,Powley I R,et al. Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease[J]. Cell Death Differ,2016,23(7):1152-1164. doi: 10.1038/cdd.2015.165
[10]	Manning L S,Whitaker D,Murch A R,et al. Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions[J]. Int J Cancer,1991,47(2):285-290. doi: 10.1002/ijc.2910470219
[11]	Kobayashi M,Takeuchi T,Ohtsuki Y. Establishment of three novel human malignant pleural mesothelioma cell lines: Morphological and cytogenetical studies and EGFR mutation status[J]. Anticancer Res,2008,28(1a):197-208.
[12]	Philippeaux M M,Pache J C,Dahoun S,et al. Establishment of permanent cell lines purified from human mesothelioma: Morphological aspects,new marker expression and karyotypic analysis[J]. Histochem Cell Biol,2004,122(3):249-260. doi: 10.1007/s00418-004-0701-1
[13]	Kanellakis N I,Asciak R,Hamid M A,et al. Patient-derived malignant pleural mesothelioma cell cultures: A tool to advance biomarker-driven treatments[J]. Thorax,2020,75(11):1004-1008. doi: 10.1136/thoraxjnl-2020-215027
[14]	Oey H,Daniels M,Relan V,et al. Whole-genome sequencing of human malignant mesothelioma tumours and cell lines[J]. Carcinogenesis,2019,40(6):724-734. doi: 10.1093/carcin/bgz066
[15]	Szulkin A,Nilsonne G,Mundt F,et al. Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy[J]. PLoS One,2013,8(6):e65903.
[16]	Yuile A,Satgunaseelan L,Wei J Q,et al. CDKN2A/B homozygous deletions in astrocytomas: A literature review[J]. Curr Issues Mol Biol,2023,45(7):5276-5292. doi: 10.3390/cimb45070335
[17]	Pozdeyev N,Gay L M,Sokol E S,et al. Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers[J]. Clin Cancer Res,2018,24(13):3059-3068.
[18]	Fortin Ensign S P,Jenkins R B,Giannini C,et al. Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma[J]. Neuro Oncol,2023,25(1):28-36. doi: 10.1093/neuonc/noac205
[19]	Yang L,Ma D W,Cao Y P,et al. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression[J]. Theranostics,2021,11(8):3742-3759. doi: 10.7150/thno.53023
[20]	Yang J,Liu Y,He A,et al. Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B[J]. Oncotarget,2017,8(40):68721-68729. doi: 10.18632/oncotarget.19878
[21]	Cao K,Li B,Zhang Y W,et al. miR-29b restrains cholangiocarcinoma progression by relieving DNMT3B-mediated repression of CDKN2B expression[J]. Aging (Albany NY),2021,13(4):6055-6065. doi: 10.18632/aging.202549
[22]	Boldrin E,Gaffo E,Niedermayer A,et al. MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia[J]. Blood,2021,138(20):1953-1965. doi: 10.1182/blood.2020007591

Relative Articles(20)

Relative Articles

[1]	Zhuohui LIU, Shiyin QIN, Hexiang ZHAO, Fengfeng JIA, Biao RUAN, Ruiqing LONG. Inhibitory Effect of Crocin on Pituitary Adenomas via IRF7/NF-κB Signaling Pathway. Journal of Kunming Medical University, 2024, 46(): 1-9.
[2]	Yuru ZHAI, Yan BAI, Yunyun LI. FGF2 Regulates Hypoxia-Induced Proliferation and Collagen Metabolism of Scleral Fibroblasts Through the PERK/EIF2α/ATF4 Signaling Pathway. Journal of Kunming Medical University, 2024, 45(10): 22-28. doi: 10.12259/j.issn.2095-610X.S20241004
[3]	Ling WANG, Xiangchuan QIN, Jinqiu LI, Hasim AXIANGU. CD147 Mediates Cervical Cancer Cell Pyroptosis and Proliferation through AIM2 Inflammasome. Journal of Kunming Medical University, 2024, 45(1): 15-21. doi: 10.12259/j.issn.2095-610X.S20240103
[4]	Xiangchuan QIN, Jinqiu LI, Xiaojing HUANG, Kuerban HUTUBIDING·, Hasim AXIANGU·. Effect of HPV E6 on Proliferation，Invasion and Migration of Cervical Cancer Cells Through Rap1 Signaling Pathway. Journal of Kunming Medical University, 2024, 45(9): 9-16. doi: 10.12259/j.issn.2095-610X.S20240902
[5]	Yi FENG, Xiaofeng WANG, Ximin BAI, Sheng YAO, Juntao DANG, Yunjie ZHAO, Bing CAI. miR-149-5p Regulates Malignant Biological Behavior of Glioma Cells Through MSH5/WNT Signaling Pathway. Journal of Kunming Medical University, 2023, 44(8): 59-70. doi: 10.12259/j.issn.2095-610X.S20230823
[6]	Liang ZHANG, Baoquan WANG, Xifeng LEI, Xu WANG, Yang KE, Wei ZHANG. Effect of miR-29c-3p/IGF1 Molecular Axis on Activation，Proliferation and Apoptosis of Hepatic Stellate Cells. Journal of Kunming Medical University, 2023, 44(9): 7-14. doi: 10.12259/j.issn.2095-610X.S20230926
[7]	Dongxing XU, Bo TANG, Guo ZHU, Xuefen LEI, Qiuhong WANG, Dong WEI. Effect and Mechanism of Twist1 Regulating Bmi1 on Invasion and Migration of Gallbladder Carcinoma Cells. Journal of Kunming Medical University, 2023, 44(3): 28-33. doi: 10.12259/j.issn.2095-610X.S20230320
[8]	Bangqing LIU, Jianfeng LI, Xiaohui LIU, Jinnan ZHANG, Jinping LIANG. MiR-196b Promotes Proliferation and Migration of Lung Adenocarcinoma by Targeting ERG. Journal of Kunming Medical University, 2023, 44(10): 83-91. doi: 10.12259/j.issn.2095-610X.S20231023
[9]	Bing CAI, Wei ZHANG, Jing LIU, Yi LIU. miR-218-5p Inhibits the Development of Colon Cancer by Regulating LAYN. Journal of Kunming Medical University, 2023, 44(12): 32-40. doi: 10.12259/j.issn.2095-610X.S20231206
[10]	Bin ZHAO, Yuanpeng DUAN, Guoying ZHANG, Chengwei BI, Libo YANG, Zhiyu SHI, Yong YANG, Jianpeng ZHANG, Ting GAO. CircRNA EZH2 Promotes Proliferation and Migration of Prostate Cancer Cells by Regulating miR-30c-5p. Journal of Kunming Medical University, 2022, 43(7): 25-32. doi: 10.12259/j.issn.2095-610X.S20220731
[11]	Wei ZHANG, Baoquan WANG, Xifeng LEI, Xu WANG, Liang ZHANG. miR-125b-5p Regulates HK2 to Inhibit Proliferation and Glycolysis of Gallbladder Cancer Cells. Journal of Kunming Medical University, 2022, 43(12): 23-29. doi: 10.12259/j.issn.2095-610X.S20221206
[12]	Ai-ping XU, Hua LIN, Li-hui GAO, Ling LI, Meng-wei CHENG, Ge WANG, Juan YANG, Yan-fen NIU. Effect of Norathyriol on the Epithelial-mesenchymal Transition of HK-2 Cells Induced by TGF-β1. Journal of Kunming Medical University, 2021, 42(7): 1-6. doi: 10.12259/j.issn.2095-610X.S20210701
[13]	Lan YANG, Xiao JIA, Yi-tong JIANG, Qi CUI, Guang-ci LIU, Ying-hong HE. The Effect of Silencing of UBE2C Gene on the Proliferation and Migration of Human Gastric Cancer AGS Cells. Journal of Kunming Medical University, 2021, 42(5): 18-23. doi: 10.12259/j.issn.2095-610X.S20210504
[14]	Li Shan Shan , Quan Yu Hang , Gong Ling Li , Yang Hui , Pu Jing Hong , Wang Zhong Hui . . Journal of Kunming Medical University, 2020, 41(05): 103-107.
[15]	Zhang Feng Lan , Zhao Yu , Yuan Jing , Yang Lu Jun , Lu Lin . Effect of Ginsenoside Rg3 on Mouse Neural Stem Cells Proliferation in Vitro. Journal of Kunming Medical University, 2018, 39(07): 10-14.
[16]	Liang Nai Chao . Correlation between Expression of MMP-9， TIMP-1 and VEGF and the Invasion of Non Small Cell Lung Cancer. Journal of Kunming Medical University,
[17]	Shi Zhao Kun . . Journal of Kunming Medical University,
[18]	Wang Hai Feng . . Journal of Kunming Medical University,
[19]	Liu Feng . . Journal of Kunming Medical University,
[20]	Liu Jia Xin . . Journal of Kunming Medical University,